Trends Shaping the Future
of Emerging Biotechs

Increasing demand for large molecule drugs has presented both opportunity
and incentive for small and emerging biotechs. However, without access to the
resources of big pharma, innovators must continually pivot to stay up-to-date
on regulatory requirements and develop novel strategies to secure funding.

• Types of therapeutics and delivery methods in biotechs’ pipelines
• Strategies employed by small biotechs to secure funding and investment
• What small biotechs look for when selecting an outsourcing partner
• The drivers behind emerging biotechs’ decisions to commercialize or license